- Source type
- Trial registry
- Access type
- Official
- Publisher
- ClinicalTrials.gov
- Added
- 2026-06-19
Trust profile
84
Clinical trial registry
- Publisher type
- Trial registry
- Bias profile
- Moderate
Best used for
- Trial status
- Protocol and endpoint discovery
Weak for
- Unpublished results
- Clinical conclusions
Used in Viral Vitalism
GLP-1s, Dopamine, and Addiction: The Substance Use Signal
Roles: Background
Show section-level references
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
No structured study record is currently attached to this source.
Related sources
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections
GLP-1R Agonist Treatment for Opioid Use Disorder
Trial registry testing whether semaglutide can reduce illicit opioid use in adults in outpatient OUD treatment.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Semaglutide for Alcohol Use Disorder
Trial registry for early-phase semaglutide AUD trial.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 4 connections
Semaglutide Therapy for Alcohol Reduction
Trial registry for semaglutide therapy for alcohol reduction.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
